×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Hambleton Julie

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SWTXSpringWorks Therapeutics, Inc.Hambleton JulieDirectorJun 03, 2024Sale$40.034,648186,0485,797Jun 05, 2024, 04:08 PM
SWTXSpringWorks Therapeutics, Inc.Hambleton JulieDirectorJul 19, 2023Sale$29.312,41870,8764,648Jul 21, 2023, 04:13 PM
SWTXSpringWorks Therapeutics, Inc.Hambleton JulieDirectorJun 20, 2023Sale$26.922,40064,6037,066Jun 22, 2023, 04:06 PM
SWTXSpringWorks Therapeutics, Inc.Hambleton JulieDirectorMar 15, 2023Sale$31.501,10634,8414,818Mar 16, 2023, 04:31 PM
IGMSIGM Biosciences, Inc.Hambleton JulieDirectorAug 09, 2021Sale$80.001,00080,0002,000Aug 11, 2021, 09:37 PM
ERASErasca, Inc.Hambleton JulieDirectorJul 20, 2021Buy$16.006,00096,0006,000Jul 20, 2021, 08:43 PM
IGMSIGM Biosciences, Inc.Hambleton JulieDirectorJun 01, 2021Sale$80.002,000160,0003,000Jun 03, 2021, 08:29 PM
IGMSIGM Biosciences, Inc.Hambleton JulieDirectorSep 18, 2019Buy$18.315,00091,5505,000Sep 20, 2019, 09:10 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerNov 11, 2015Option Exercise$9.3822,000206,28097,919Nov 13, 2015, 05:04 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerNov 11, 2015Sale$34.6323,108800,23889,319Nov 13, 2015, 05:04 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerAug 22, 2014Buy$10.754004,3001,700Oct 30, 2015, 06:09 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerSep 18, 2013Buy$14.7580011,800800Oct 30, 2015, 06:09 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerSep 30, 2013Buy$13.706487764Oct 30, 2015, 06:09 PM
FPRXFIVE PRIME THERAPEUTICS INCHambleton JulieEVP & Chief Medical OfficerNov 06, 2013Buy$10.105005,0501,300Oct 30, 2015, 06:09 PM